Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2013

News provided by

Sep 12, 2013, 11:14 ET

NEW YORK, Sept. 12, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0611576/Inflammatory-Bowel-Disease-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Summary

GlobalData's clinical trial report, "Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2013" provides data on the Inflammatory Bowel Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inflammatory Bowel Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inflammatory Bowel Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Inflammatory Bowel Disease 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Inflammatory Bowel Disease 24

Subjects Recruited Over a Period of Time 32
Prominent Sponsors 33
Top Companies Participating in Inflammatory Bowel Disease Therapeutics Clinical Trials 35
Prominent Drug Comparison 37
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
AbbVie Inc. 38
Clinical Trial Overview of AbbVie Inc. 38
UCB S.A. 40
Clinical Trial Overview of UCB S.A. 40
Pfizer Inc. 42
Clinical Trial Overview of Pfizer Inc. 42
GlaxoSmithKline plc 43
Clinical Trial Overview of GlaxoSmithKline plc 43
Merck & Co., Inc. 44
Clinical Trial Overview of Merck & Co., Inc. 44
Ferring Pharmaceuticals, Inc. 45
Clinical Trial Overview of Ferring Pharmaceuticals, Inc. 45
Alvine Pharmaceuticals, Inc. 46
Clinical Trial Overview of Alvine Pharmaceuticals, Inc. 46
AstraZeneca PLC 47
Clinical Trial Overview of AstraZeneca PLC 47
Genzyme Corporation 48
Clinical Trial Overview of Genzyme Corporation 48
Alba Therapeutics Corporation 49
Clinical Trial Overview of Alba Therapeutics Corporation 49
Given Imaging Ltd. 50
Clinical Trial Overview of Given Imaging Ltd. 50
Amgen Inc. 51
Clinical Trial Overview of Amgen Inc. 51
Osiris Therapeutics, Inc. 52
Clinical Trial Overview of Osiris Therapeutics, Inc. 52
Johnson & Johnson 53
Clinical Trial Overview of Johnson & Johnson 53
Teva Pharmaceutical Industries Limited 54
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 54
ChemoCentryx, Inc. 55
Clinical Trial Overview of ChemoCentryx, Inc. 55
Elan Pharmaceuticals, Inc. 56

Clinical Trial Overview of Elan Pharmaceuticals, Inc. 56
Dr. Falk Pharma GmbH 57
Clinical Trial Overview of Dr. Falk Pharma GmbH 57
Schering-Plough Limited 58
Clinical Trial Overview of Schering-Plough Limited 58
Isis Pharmaceuticals, Inc. 59
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 59
Clinical Trial Overview of Top Institutes / Government 60
Tel-Aviv Sourasky Medical Center 60
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 60
The National Institute of Allergy and Infectious Diseases 61
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 61
Academic Medical Centre 62
Clinical Trial Overview of Academic Medical Centre 62
Keio University 63
Clinical Trial Overview of Keio University 63
University of Pittsburgh 64
Clinical Trial Overview of University of Pittsburgh 64
Indiana University 65
Clinical Trial Overview of Indiana University 65
Hyogo College Of Medicine 66
Clinical Trial Overview of Hyogo College Of Medicine 66
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 67
Clinical Trial Overview of Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 67
Beth Israel Deaconess Medical Center 68
Clinical Trial Overview of Beth Israel Deaconess Medical Center 68
The University of British Columbia 69
Clinical Trial Overview of The University of British Columbia 69
Asan Medical Center 70
Clinical Trial Overview of Asan Medical Center 70
Mayo Clinic 71
Clinical Trial Overview of Mayo Clinic 71
Tokyo Medical and Dental University 72

Clinical Trial Overview of Tokyo Medical and Dental University 72
Department of Health, UK 73
Clinical Trial Overview of Department of Health, UK 73
Vanderbilt University 74
Clinical Trial Overview of Vanderbilt University 74
Johns Hopkins University 75
Clinical Trial Overview of Johns Hopkins University 75
The University of Western Ontario 76
Clinical Trial Overview of The University of Western Ontario 76
Leiden University Medical Center 77
Clinical Trial Overview of Leiden University Medical Center 77
VU University Medical Center 78
Clinical Trial Overview of VU University Medical Center 78
University of Alberta 79
Clinical Trial Overview of University of Alberta 79
Five Key Clinical Profiles 80
Appendix 200
Abbreviations 200
Definitions 200
Research Methodology 201
Secondary Research 201
About GlobalData 202
Contact Us 202
Disclaimer 202
Source 203

List of Tables

Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Inflammatory Bowel Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Inflammatory Bowel Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Inflammatory Bowel Disease Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Inflammatory Bowel Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 14
Inflammatory Bowel Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
Inflammatory Bowel Disease Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Inflammatory Bowel Disease Therapeutics Clinical Trials, G7 Countries, 2013* 17
Inflammatory Bowel Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Inflammatory Bowel Disease Therapeutics Clinical Trials, E7 Countries, 2013* 19
Inflammatory Bowel Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22

Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Inflammatory Bowel Disease Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Inflammatory Bowel Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Inflammatory Bowel Disease Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 32
Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 34
Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 36
Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 37
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2013* 38
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2013* 40
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 42
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 43
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 44

Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring Pharmaceuticals, Inc., 2013* 45
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Alvine Pharmaceuticals, Inc., 2013* 46
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 47
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2013* 48
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Alba Therapeutics Corporation, 2013* 49
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Given Imaging Ltd., 2013* 50
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2013* 51
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osiris Therapeutics, Inc., 2013* 52
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 53
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 54
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by ChemoCentryx, Inc., 2013* 55
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Elan Pharmaceuticals, Inc., 2013* 56
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Falk Pharma GmbH, 2013* 57

Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Limited, 2013* 58
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2013* 59
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2013* 60
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 61
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013* 62
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2013* 63
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 64
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2013* 65
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2013* 66
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, 2013* 67
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2013* 68
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2013* 69
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2013* 70
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 71
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Medical and Dental University, 2013* 72
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2013* 73
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 74
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 75
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Western Ontario, 2013* 76
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2013* 77
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2013* 78
Inflammatory Bowel Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2013* 79

List of Figures

Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Inflammatory Bowel Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Inflammatory Bowel Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Inflammatory Bowel Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Inflammatory Bowel Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 14
Inflammatory Bowel Disease Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15
Inflammatory Bowel Disease Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Inflammatory Bowel Disease Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Inflammatory Bowel Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Inflammatory Bowel Disease Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Inflammatory Bowel Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Inflammatory Bowel Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 32
Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 33
Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 35
Inflammatory Bowel Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 37
GlobalData Methodology 201